CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- 4 Open-market buy Director bought 25,000 shares at $4.54 ($113,500)
- 4 Open-market buy Director bought 501,041 shares at an average $1.08 ($543,100)
- 4 Open-market buy Director bought 50,000 shares at $4.26 ($213,165)
- 4 Open-market buy Chief Financial Officer bought 7,831 shares at $4.09 ($32,029)
- 4 Open-market buy Director bought 50,000 shares at $3.88 ($193,800)
- 4 Open-market buy CCO and General Counsel bought 7,400 shares at $4.12 ($30,488)
- 4 Open-market buy Director bought 2,000 shares at $4.89 ($9,780)
- 4 Open-market buy Chief Technology Officer bought 1,848 shares at an average $4.80 ($8,875)
- 4 Open-market buy Chief Technology Officer bought 2,197 shares at an average $4.55 ($9,995)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 96,349 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Former Director bought 41,697 shares at $7.19 ($299,655)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Business Officer bought 6,400 shares at $7.69 ($49,241)
- 4 Open-market buy Chief Business Officer bought 4,000 shares at $7.37 ($29,475)
- 4 Open-market buy Director bought 2,000 shares at $6.78 ($13,566)
Page 7 of 12 · 230 filings